naltrexone and Stomach Neoplasms

naltrexone has been researched along with Stomach Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aoyagi, K; Ashikawa, M; Chiwaki, F; Fujita, T; Fukagawa, T; Katai, H; Komatsu, M; Kushima, R; Nagase, H; Nakagama, H; Narita, M; Sakamoto, H; Sasaki, H; Sawada, Y; Suzuki, M; Suzuki, T; Uezono, Y; Yanagihara, K; Yoshida, T	1

Other Studies

1 other study(ies) available for naltrexone and Stomach Neoplasms

Article	Year
Peripheral opioid antagonist enhances the effect of anti-tumor drug by blocking a cell growth-suppressive pathway in vivo. PloS one, 2015, Volume: 10, Issue:4 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Cycle; Cell Proliferation; Docetaxel; Drug Synergism; Growth Inhibitors; Humans; Mice; Naltrexone; Narcotic Antagonists; Quaternary Ammonium Compounds; Receptors, Opioid; Stomach Neoplasms; Taxoids	2015

Article

Year

Peripheral opioid antagonist enhances the effect of anti-tumor drug by blocking a cell growth-suppressive pathway in vivo.

PloS one, 2015, Volume: 10, Issue:4

Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Cycle; Cell Proliferation; Docetaxel; Drug Synergism; Growth Inhibitors; Humans; Mice; Naltrexone; Narcotic Antagonists; Quaternary Ammonium Compounds; Receptors, Opioid; Stomach Neoplasms; Taxoids

2015